Patricia Tresca

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Genomic Alterations in Head and Neck Squamous Cell Carcinoma: Level of Evidence According to ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT).

Genomic Alterations in Head and Neck Squamous Cell Carcinoma: Level of Evidence According to ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT).

Journal: JCO precision oncology

Published: January 07, 2022

Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy.

Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy.

Journal: Drugs in R&D

Published: September 01, 2021

Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial.

Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial.

Journal: ESMO open

Published: January 12, 2021

Sustained Tumor Control With MAPK Inhibition in BRAF V600-Mutant Adult Glial and Glioneuronal Tumors.

Sustained Tumor Control With MAPK Inhibition in BRAF V600-Mutant Adult Glial and Glioneuronal Tumors.

Journal: Neurology

Published: December 17, 2020

A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial.

A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial.

Journal: NPJ precision oncology

Published: September 24, 2020

Fine-needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology: prospective comparative study of next-generation sequencing in cancer patients included in the SHIVA02 trial.

Fine-needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology: prospective comparative study of next-generation sequencing in cancer patients included in the SHIVA02 trial.

Journal: Molecular oncology

Published: April 27, 2020

Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets.

Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 19, 2019

Relevance of a molecular tumour board (MTB) for patients' enrolment in clinical trials: experience of the Institut Curie.

Relevance of a molecular tumour board (MTB) for patients' enrolment in clinical trials: experience of the Institut Curie.

Journal: ESMO open

Published: February 08, 2018

Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis.

Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 13, 2017

From prospective biobanking to precision medicine: BIO-RAIDs - an EU study protocol in cervical cancer.

From prospective biobanking to precision medicine: BIO-RAIDs - an EU study protocol in cervical cancer.

Journal: BMC cancer

Published: August 06, 2015

A phase I pharmacokinetic study of the vascular disrupting agent ombrabulin (AVE8062) and docetaxel in advanced solid tumours.

A phase I pharmacokinetic study of the vascular disrupting agent ombrabulin (AVE8062) and docetaxel in advanced solid tumours.

Journal: British journal of cancer

Published: October 30, 2013

Circulating tumor cells and brain metastasis outcome in patients with HER2-positive breast cancer: the LANDSCAPE trial.

Circulating tumor cells and brain metastasis outcome in patients with HER2-positive breast cancer: the LANDSCAPE trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 10, 2013

Showing 1-12 of 16

Last Updated: 09/26/2026